Abstract | OBJECTIVE: METHODS: RESULTS: Among them, 77 patients were evaluated. There were 49 males and 28 females with a mean age of (69±20) years. The Acute Physiology and Chronic Health Evaluation (APACHE) II score was 15±5. Among whom 61 had hospital-acquired pneumonia (n=61), primary bacteremia (n=5), intra-abdominal infection (n=3), skin and soft tissue infection (SSTI) (n=2) and multiple sites infection (n=6). Twenty-three patients had mixed bacterial infections. Combined use of imipenem-cilastatin therapy was administered in 7 patients. The treatment duration was (16±4) days. The outcomes were cure (n=21), marked improvement (n=27), improvement (n=26) and ineffectiveness (n=3). The overall effective rate was 62.3% (48/77) and the microbiological clearance rate 46.8% (36/77). The independent factors of decreased efficacy were underlying co-morbidity of impaired ability for infection control (OR=5.3, P=0.020), prolonged infection (OR=3.8, P=0.029), co-infecting organism (OR=3.5, P=0.032) and septic shock (OR=2.5, P=0.037). CONCLUSIONS: The combined regimen of C/S and minocycline is efficacious in the treatment of infections caused by XDRAB. But it has a lower rate of microbiological eradication.
|
Authors | Yan Shi, Ying-chun Xu, Ye Liu, Wei Du, Xi Rui, Yao Wang |
Journal | Zhonghua yi xue za zhi
(Zhonghua Yi Xue Za Zhi)
Vol. 92
Issue 40
Pg. 2847-50
(Oct 30 2012)
ISSN: 0376-2491 [Print] China |
PMID | 23290215
(Publication Type: Journal Article)
|
Chemical References |
- Cefoperazone
- Minocycline
- Sulbactam
|
Topics |
- Acinetobacter Infections
(drug therapy, microbiology)
- Acinetobacter baumannii
(drug effects)
- Aged
- Aged, 80 and over
- Cefoperazone
(administration & dosage, therapeutic use)
- Cross Infection
(drug therapy, microbiology)
- Drug Resistance, Bacterial
- Drug Therapy, Combination
- Female
- Humans
- Male
- Middle Aged
- Minocycline
(administration & dosage, therapeutic use)
- Prospective Studies
- Sulbactam
(administration & dosage, therapeutic use)
|